Prof. David Planchard is an onco-pulmonologist and head of the Thoracic Pathology Committee of Gustave Roussy. He is an expert in biomarkers, targeted treatment of bronchial cancers and in immunotherapy. He has been involved in more than 100 Phase I-III trials and has published more than 130 articles in renowned international journals.
Prof. Planchard co-directs clinical trials on thoracic tumors to develop a long-term clinical research strategy based on molecular screening. He has coordinated the drafting of the latest European recommendations on the management of advanced non-small cell lung cancer (ESMO guidelines) and is involved in national and international conferences such as ESMO, ELCC, ASCO and WCLC.
Prof. Planchard is a member of the French-language Respiratory Society (SPLF) and the French Intergroup of Thoracic Oncology (IFCT), ESMO, ASCO, AACR. It also participates in the national network of thymic tumors (RYTHMIC), the national expert network for malignant pleural mesothelioma (MESOCLIN) and the national network for the management of neuroendocrine tumors (RENATEN).